Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.5984 USD | +3.00% | -8.08% | -27.18% |
May. 30 | Brookline Capital Initiates Forte Biosciences at Buy Rating With $4 Price Target | MT |
May. 13 | Forte Biosciences, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Chart: Technical Analysis
Technical analysis trends
Short Term | Mid-Term | Long Term | |
---|---|---|---|
Trend | Bearish | Neutral | Neutral |
Resistance | 0.6710 | 0.8500 | 1.040 |
Spread/Res. | -10.82% | -29.60% | -42.46% |
Spread/Supp. | +3.19% | +23.74% | +36.06% |
Support | 0.5799 | 0.4836 | 0.4398 |
Technical Rankings Surperformance
Short Term Timing | |
---|---|
Middle Term Timing | |
Long Term Timing | |
RSI | |
Bollinger Spread | |
Unusual Volumes |
- Stock Market
- Equities
- FBRX Stock
- Charts Forte Biosciences, Inc.